In the world of Chinese humanoid robotics, there's a phrase making the rounds among founders and investors: "Listing is a must." That's not bravado — it's a strategic calculus. And according to a new report from CNBC, the rush to public markets among Chinese humanoid startups is intensifying in a way that could reshape the global competitive landscape for robotics investment.

The push comes as China's robotics sector is hitting a genuine inflection point. Government policy targets over 100,000 humanoid robots produced domestically in 2026. Valuations are surging. And a string of funding rounds and regulatory approvals in recent weeks has turned what was a rumble into a stampede.

The Deals Piling Up

The numbers are striking in their variety and velocity:

Unitree Robotics received CSRC (China Securities Regulatory Commission) approval for a ~$619 million Shanghai Star Market IPO — the fastest-ever review cycle on that exchange, at 104 days. The company behind the G1 and H1 humanoids, and the viral quad-robot demos, is on a glide path to public markets.

Zeroth (ZeroBot), a humanoid startup backed by Ant Group in a $74 million pre-Series A, is building wheeled and legged robots for industrial deployment. The Ant imprimatur brings significant ecosystem reach.

AI² Robotics, a wheeled-humanoid-focused startup, raised $735 million at a $3 billion valuation — a staggering number for a company in this stage of hardware development, suggesting investors are pricing in future market dominance, not current revenue.

Agibot — the SoftBank-adjacent company that has deployed semi-humanoid robots in electronics manufacturing — has been accelerating its European growth roadmap, hinting at cross-border ambitions that would benefit from public capital and brand credibility.

Across these and others, a pattern emerges: Chinese humanoid startups are treating the IPO not as an exit but as a tool. Capital from public markets funds the infrastructure — factories, supply chains, data collection at scale — that turns a promising robot into a dominant platform.

Why "Listing Is a Must"

In a conversation with CNBC, founders explained the calculus bluntly. Public listings provide:

1. Large-scale capital that private rounds can't match, especially for capex-heavy hardware companies that need to manufacture at volume.

2. Credibility with enterprise customers and government procurement, where a public company with audited financials is a safer vendor than a well-funded startup.

3. Liquidity for early employees and investors, whi

ch in turn allows companies to recruit top talent with competitive equity packages.

4. Brand visibility in a market where consumer and enterprise perception matter as much as technical specs.

The analogy is to China's EV sector, where companies like BYD and NIO used public listings to access capital at scale, outpace foreign competition on price and volume, and establish global brand recognition. Humanoid robot founders are explicitly citing that playbook.

The US Comparison

The dynamic in the US is different but converging. Agility Robotics is going public via a $2.5 billion SPAC merger. Figure AI — whose robots recently completed 17-hour shifts sorting packages — remains private at an estimated $2.6 billion valuation but faces pressure to either generate revenue or seek more capital. Boston Dynamics, owned by Hyundai, is reportedly eyeing a dual listing despite regulatory headwinds.

The difference is timing and scale. Chinese companies appear willing to list earlier, at smaller revenues, with higher tolerance for investor uncertainty. This isn't necessarily reckless — in a market where government support is strong and the technology is advancing monthly, early listing can lock in capital advantages before the competitive landscape consolidates.

What This Means for the Global Market

If the current wave of Chinese humanoid IPOs proceeds as planned, it will create a cohort of well-capitalized, publicly accountable robotics companies with shareholder pressure to deploy at scale, reduce costs, and expand internationally. That's a significant forcing function.

For US and European competitors, the race is no longer just technical. It's financial and commercial. Whoever reaches mass production first — with robots reliable enough for real deployments, cheap enough to undercut human labor, and backed by capital deep enough to sustain the losses that come with early-stage manufacturing at volume — holds a structural advantage that compounds over time.

Chinese humanoid startups appear to have calculated that public markets are the fastest path to that scale. The next 18 months, as these IPOs progress and post-listing performance data emerges, will tell us whether they're right.

Source: CNBC via Google News. For investors tracking the robotics space, the Global X Robotics & AI ETF (BOTZ) and ROBO Global Robotics & Automation ETF (ROBO) offer broad exposure to the sector, including Chinese and US players.

---

Tags: China robotics, Unitree IPO, humanoid robots, robotics investment, robot stocks, AI² Robotics, Zeroth, Agibot